...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ... just for whatever reason...

The RBC group has beeen in contact with Zenith. They contacted me yesterday afternoon noting they will transfer ZENE shares as soon as the new valuation from Zenith is posted. So maybe sometime in the next couple of weeks we get a new letter from our CFO. Just a heads up as it has been a battle so far with RBC to perform DD in regards to this share transfer and their eligibility in a TFSA. I cant say that RBC contacted the CRA but it seems they dont want to middleman for their clients. I just find that odd when you are in the business to provide a borkerage investing service.

3
Jan 19, 2019 08:31PM
3
Jan 20, 2019 03:12AM
3
Jan 20, 2019 12:38PM
1
Jan 20, 2019 07:36PM
Share
New Message
Please login to post a reply